Life Sciences IP Review

26/07/2024

Brochure released! Adalvo, Cancer Research UK, EuroImmun, and Regeneron confirmed to speak at LSPN Europe 2024!

Join us at Europe’s leading event for IP professionals in life sciences. December 3rd in London

Download the brochure now to see the confirmed speakers, updated agenda, exclusive discounts, and more. Whether you’re a patent attorney, in-house counsel, researcher, or industry expert, this is your chance to gain invaluable insights, network with peers, and stay ahead in the ever-evolving life science patent landscape.

Don’t miss out – download the brochure today: https://bit.ly/3YmoDf5

26/07/2024

Lewis Roca has promoted Constantine Marantidis as managing partner of the firm’s California offices, with immediate effect.

Read more on the promotion here:

Lewis Roca promotes aerospace and tech expert to managing partner

26/07/2024

Panitch Schwarze has strengthened its life sciences provision with the addition of counsel George Wu, who has a PhD in molecular biology and extensive experience representing pharmaceutical and biotechnology clients.

Panitch Schwarze partner Travis Bliss said: “He is an accomplished scientist and patent attorney with a wealth of experience navigating the intellectual property considerations of life science practitioners.”

Read more on the appointment here: https://ow.ly/h9Es50SKHKt

Panitch Schwarze brings in molecular biologist

26/07/2024

AI has the potential to revolutionise patent examination but uneven adoption of the technology could undermine fairness in the system, says Matthew Veale of Patsnap.

As both patent attorneys and patent examiners adopt these advanced technologies, the potential for an ‘arms race’ emerges, with significant implications for drafting, prosecution, search and examination processes.

Read more insights here: https://ow.ly/iBUA50SKHGV

Attorney v examiner: Navigating patenting's AI tools ‘arms race’

26/07/2024

Chinese RNA specialist Hongene Biotech has knocked out a patent belonging to US competitor ChemGenes, after the US Patent Trial and Appeal Board (PTAB) ruled that all challenged claims were unpatentable.

Hongene Biotech contested the patent after ChemGenes attempted to assert it in a suit filed in Massachusetts in 2022, which was subsequently withdrawn.

Read the full story here: https://ow.ly/kBKP50SKHB4

23/07/2024

Edwards Lifesciences won at the Unified Patent Court’s Paris Central Division, defeating a revocation claim and two counterclaims by Meril entities. The dispute involves Edwards' patent for minimally invasive heart surgery technology.

Read more on the story here: https://ow.ly/zbt150SImHt

23/07/2024

US lawmakers are aiming to amend legislation to cap the number of patents biologics manufacturers can assert, facilitating generic market entry and reducing prescription costs.

The Affordable Prescriptions for Patients Act of 2024 was introduced by Congressman Darrell Issa and Ranking Member Hank Johnson.

Read the full story here: https://ow.ly/KGYl50SImqq

US targets ‘product hopping’ with biologic litigation curbs

19/07/2024

Don’t forget, our super early bird offer for the Technology Patent Network (TPN) North America ends today at midnight. You won’t want to miss this premier event for patent professionals in the tech sector!

What sets this event apart from other IP conferences this year?

Our agenda tackles the most pressing topics in the industry, led by industry experts. TPN North America will bring together over 150 IP leaders and experts to rethink how they protect their IP and deliver value. We’ll share winning tactics in portfolio management, litigation, and licensing, ensuring you:

• STAY UPDATED ON THE LATEST TRENDS: Our speakers will provide insights on the newest IP trends, regulations, and best practices in the technology sector, including strategies for monetizing and licensing your IP assets, and more.
• BENCHMARK YOUR BEST PRACTICES: Engage in roundtable discussions on protecting trade secrets, managing diverse teams, and coping with portfolio unpredictability to share and learn best practices from fellow professionals.
• NETWORK WITH INDUSTRY LEADERS: Utilize networking opportunities with peers, industry experts, and potential partners or clients during registration, coffee breaks, lunch, and afternoon tea breaks.
• IDENTIFY BUSINESS OPPORTUNITIES: TPN North America offers a platform for businesses to showcase their products and services, providing you the chance to discover new business opportunities or partnerships.

Secure your seat before midnight and save $650: https://bit.ly/3xkAb7D

19/07/2024

The UK Intellectual Property Office (IPO) filed its first patent application using the new digital One IPO service. This includes an AI tool that directs applications in seconds, down from 14 days. The service is currently in private testing and will launch to all customers in early 2025.

Peter Kyle, the Secretary of State for Science, Innovation and Technology, described the service as “a true revolution in efficiency”.

Read the full story here: https://ow.ly/uOue50SFRby

19/07/2024

The USPTO announced that AI involvement in inventions does not affect patent eligibility. On July 16, 2024, it released guidelines clarifying criteria for patenting AI innovations, focusing on how examiners assess claims under ineligible categories as outlined in Supreme Court cases like Alice Corp v CLS Bank and Mayo v Prometheus.

Kathi Vidal, under secretary of commerce for IP and director of the USPTO, said: “The USPTO remains committed to fostering and protecting innovation in critical and emerging technologies, including AI.”

Read more on the story here: https://ow.ly/wLSm50SFR4J

19/07/2024

The US International Trade Commission concluded that California-based Gator Bio did not infringe Sartorius Bioanalytical Instruments' patent. Sartorius had accused Gator Bio of IP infringement related to bio-layer interferometers, biosensors, and related kits.

Sartorius was represented by Haug Partners in the matter; Gator Bio by Perkins Coie.

Read more on the story here: https://ow.ly/OQmP50SFQGN

18/07/2024

We have an electrifying line-up of speakers at this year’s LSPN North America–Fall conference, featuring top pharma and biotech patent attorneys.

Newly confirmed speakers include:

Alison Maddeford, Director, Litigation & Risk Management, Thermo Fisher Scientific will share her thoughts on obviousness-type double patenting
Randy Wu Vice President of Intellectual Property and Litigation, 10x Genomics will add his insights to our international harmonization and global patent strategies panel
Alyson Fuller VP, Government Affairs & Intellectual Property, Prolacta Bioscience will delve into the expanded role of patent lawyers within life sciences companies
Nathaniel Leachman Corporate Counsel, Pfizer will question the patentability of AI-generated inventions
Eneda Hoxha Vice President, Intellectual Property & Business Development, ReCode Therapeutics will dig into co-owned IP and licensing disputes

Join us to hear from industry leaders addressing key challenges in life sciences IP, covering the entire patent lifecycle in the US.

Discover more and register now to secure your spot and save $650: https://ow.ly/OCLA50SF1n6

18/07/2024

If you haven't already registered yet to attend TPN North America, don't delay. The super bird discount ends this Friday, July 19! If you book today, you'll save $650 on your ticket: https://bit.ly/3xkAb7D

This industry-leading conference will take place on October 16-17 in San Francisco. As a delegate, you'll have a chance to listen to IP experts from some of the industry’s most exciting and innovative companies including:

• Nathan Zhang, Director, Global Litigation & Investigations, Applied Materials
• Jia Dailey, Director, IP, Atlassian
• Bridget Smith, Head of IP, Relativity Space
• Bill LaFontaine, Senior Advisor, IP, IBM
• Brian Dorini, Director, Senior Standards Counsel, InterDigital
• Thomas Choi, Director, Licensing, Ericsson
• Rohan, Kale, Product & IP Counsel, Elastic
• Yvonne Lee, Director, IP Investments, Parabellum Capital
• Hongming Liu, Senior IP Counsel, Tencent America
• Diane Gabl Kratz, Director, IP Strategy & Operations, Dolby
• Ruth Patterson, Manager, IP & Security, CSignum
• Khadeeja,Saleem, Senior Counsel, Technology Transactions, Rivian
• Kenneth Jenq, Legal Director, Abnormal Security
• Peter, Jovanovic, Director, IP, Dell
• Cloris, Cui, Senior IP Counsel, Futurewei Technologies

TPN North America is the only event on the West Coast bringing together 150+ patent professionals focussing solely on the tech industry. Secure your ticket now and save $650: https://bit.ly/3xkAb7D

17/07/2024

Polsinelli has appointed Timothy Schaum as shareholder in the IP Litigation Practice, making the move from Daspin & Aument. Polsinelli has also added Chad Landmon as chair of the Hatch-Waxman & Biologics Practice in the Washington, DC office.

Patrick Woolley, IP department chair, said: “Chad is a recognised star in the industry, and his background in pharmaceuticals litigation, as well as FDA, provides him with a unique dual practice that is highly regarded in the market and will be a great asset to our clients.”

Read more on the appointments here: https://ow.ly/kPGC50SCYgl

17/07/2024

UK Prime Minister Keir Starmer will introduce the AI bill tomorrow, July 17, likely strengthening protections for rights owners and addressing AI use of copyrighted works.

Life sciences attorneys at Arnold & Porter warn that stricter regulations could stifle innovation in healthcare. Jacqueline Mulryne advises against imposing onerous requirements that could delay product launches.

Read the full story here: https://ow.ly/o5tT50SCY0O

17/07/2024

Sanofi and Regeneron won a Unified Patent Court (UPC) decision revoking Amgen’s monoclonal antibody patent. The case, filed on the UPC's launch day a year ago, concerns PCSK9 cholesterol-lowering antibody technology.

Daniel Wise, who represented Sanofi and Regeneron from Carpmaels & Ransford, described the win as “important” in this new, pan-European patent court.

Read more on the decision here: https://ow.ly/MXZW50SCXQY

16/07/2024

Brochure released: Must-attend event for tech patent attorneys – get your copy today!

Join us at Technology Patent Network (October 16-17, San Francisco) where 150+ IP leaders will share insights. Hear from speakers from Atlassian, Applied Materials, InterDigital, Ericsson, Dell, Rivian, Astera Labs, Elastic, Relativity Space, Dolby Labs, and more.

Download the PDF event brochure now for the first phase of speakers, detailed agenda, discounts, and more.

Click here to access your copy of the event brochure: https://bit.ly/4eDvKp0

Key sessions include:
• Demonstrating IP value amid budget constraints
• Best practices in litigation financing
• The shifting global IP landscape
• Growth of trade secrets & AI
• Dealmaking in the evolving SEP market
• Patent landscape changes in Europe
• Deploying AI in IP practice

We look forward to seeing you at the must-attend event for IP attorneys in the tech industry!

15/07/2024

Be the first to access the cutting-edge agenda for Europe's premier life sciences patent event!

The highly-anticipated 2024 LSPN Europe conference in London is primed to redefine the boundaries of innovation and we're about to release the long-awaited agenda!

Back for our 7th year in London as the patent world in Europe is undergoing a transformative shift, with groundbreaking legislation and landmark decisions reshaping the way intellectual property is protected and enforced. At LSPN Europe, we're committed to keeping you ahead of the curve, equipping you with the knowledge and insights to navigate this rapidly evolving landscape successfully.

You’ll learn how to protect and leverage IP across the life cycle of your innovation, which is the main driving force behind our event this year. Prepare to immerse yourself in a world of groundbreaking discoveries, thought-provoking discussions, and invaluable networking opportunities.

Addressing the most pressing issues for the IP world, you’ll delve into:
Aligning innovation, regulation and IP protection
International harmonization and global patent strategies
Bridging academia and industry: How can universities and industry work most effectively together?
The EU pharma package: A challenge or an opportunity for the pharma Industry
A year of the UPC: What have we done and how does it match what we expected?
But that's not all – we've curated an array of interactive roundtables, panel discussions, and one-on-one sessions via our networking app Brella to ensure you leave equipped with actionable strategies and a renewed sense of inspiration.

Register your interest now to be the first to hear who’s speaking at this year’s event: https://bit.ly/3RZiq4M

12/07/2024

What does the future hold for IP counsel? Find out at TPN San Francisco!

Join us at World IP Review’s Technology Patent Network (San Francisco, October 16-17) where industry leaders like Becky Unruh, General Counsel at EagleView Technologies, and Subroto Bose, Head of IP at Astera Labs, will discuss the new challenges and share strategies in the panel session: “The changing face of IP counsel: deliver impact to future-proof your business”.

Our stellar speaker roster includes representatives from:
• Nathan Zhang, Applied Materials
• Jia Dailey, Atlassian
• Bridget Smith, Relativity Space
• Bill LaFontaine, IBM
• Brian Dorini, InterDigital
• Thomas Choi, Ericsson
• Rohan Kale, Elastic
• Yvonne Lee, Parabellum Capital
• Hongming Liu, Tencent America
• Diane Gabl Kratz, Dolby
• Ruth Patterson, CSignum
• Khadeeja Saleem, Rivian
• Kenneth Jenq, Abnormal Security
• Peter Jovanovic, Dell
• Cloris Cui, Futurewei Technologies

Join over 100 patent professionals for networking, thought-provoking discussions, and actionable strategies to drive your IP practice forward.

Discover the full agenda and speaker lineup by accessing the event brochure here: https://bit.ly/4eDvKp0

12/07/2024

World IP Review announces the first speakers for LSPN Europe on Dec 3rd in London!

From cutting-edge gene therapies to revolutionary diagnostic tools, our expert speakers will dive deep into the most pressing challenges and opportunities shaping the future of life sciences.

Here’s a sneak peek at the 20+ experts who have already they'll be speaking this year:

Laila Beynon, Director Dispute Resolution, Regeneron
Kristine Capase Jastrzembska, IP Manager, LifeArc
Damaso Gallardo, IP Expert, European Patent Attorney, Farmaprojects
Tas Gohir, Senior Intellectual Property, Innovation and Commercial Research Manager, Guys and St Thomas's Trust, NHS
Beatrice Lana, Strategic Alliance Executive, Cancer Research UK
Nicole Mastrangelo, IP Counsel, The Broad Institute
Maria Nichol, Head of IP, Agomab
Andy Porter, Director, Chief Technical Officer, Elasmogen
Casten Richter, Head of Division IP, EuroImmun
Jiri Slavik, Director, Intellectual Property, Adalvo
Hilary van der Hoff, Vice President, Intellectual Property, T-Therapeutics
Isaac Zaghi, Patent Counsel, Endologix
This is just a glimpse into the extraordinary lineup of speakers we have assembled for LSPN Europe this year!

Register your interest now to be the first to see the full speaker list as soon as its released: https://bit.ly/3RZiq4M

12/07/2024

Nixon Peabody has added three IP partners to its West Coast offices amid "tremendous recent growth." Sasha Rao and Brandon Stroy join the San Francisco office, and Ashe Puri joins in Los Angeles, all from Maynard Nexsen.

Read more on the appointments here: https://ow.ly/KjWN50SA9Wo

12/07/2024

The FTC supports the USPTO's proposed changes to patent terminal disclaimer practice, despite opposition claiming it will harm life sciences innovation. The FTC believes the rule will reduce patent holders' "gamesmanship" and lessen the impact of patent thickets.

Read the full story here: https://ow.ly/hEF650SA9S4

12/07/2024

As weight-loss drugs like Ozempic gain popularity, Novo Nordisk face seasoned criminals and international probes to get results. The demand for these drugs, often used for diabetes, is skyrocketing. Companies are under pressure to crack down on counterfeits.

Read more on the story here:

Novo Nordisk’s uphill battle in the counterfeit weight loss craze

10/07/2024

Peter Kyle has been appointed Secretary of State for Science, Innovation, and Technology in the new UK government, overseeing IP and AI. Re-elected as MP for Hove and Portslade on July 5 with 52% of the vote, Kyle previously pledged at the Labour Party Conference to harness AI for the benefit of everyone.

Read more on the appointment here:

Labour govt appoints new Minister with IP oversight

10/07/2024

In a landmark ruling on July 4, 2024, the Unified Patent Court (UPC) revoked DexCom’s glucose monitoring patent in Europe. The UPC's Paris Local Division invalidated the patent following DexCom's complaint and Abbott's counterclaim for revocation. This was the division's first ruling on the merits and the court's second infringement decision last week.

Read more on the ruling here:

UPC’s second decision revokes patent in Europe

10/07/2024

Biotech firm BlueAllele has sued Intellia Therapeutics for patent infringement, alleging Intellia received over $100 million from Regeneron to use its gene-correcting technology for therapeutic research.

Read more on the lawsuit here:

BlueAllele says rival gained $100m from Regeneron deal using patented tech

03/07/2024

European IP firm Carpmaels & Ransford has promoted patent attorneys Daniel Goodman and Paul Kaufman to the partnership.

Hugh Goodfellow, managing partner at Carpmaels & Ransford, said the pair were “exceptional” patent attorneys.

Read more on the promotions here: https://ow.ly/cfYc50SuF9t

03/07/2024

The US Supreme Court's recent ruling on a fishing-related case overturned a long-standing legal precedent, significantly limiting federal agencies' authority, including the US Patent and Trademark Office (USPTO), in finalizing rulemaking. In a 6-3 vote on Friday, June 28, the Court rejected the 40-year-old Chevron doctrine, which previously enabled judges to defer to federal agencies' interpretations of the law.

Read more on the ruling here:

Earthquake Chevron: A massive shock to the system?

03/07/2024

Meet the leading IP professionals across more than 80 countries and six continents!

After months of rigorous research, we’re excited to announce the release of our much-anticipated list of the world’s top intellectual property lawyers in WIPR Leaders 2024.

This comprehensive online resource connects you with over 2,000 leading lawyers specialising in patent, trademark, trade secrets, and copyright practices. Each practitioner has been meticulously evaluated based on their professional track record, industry expertise, and significant contributions to the field.

When you need trusted, flexible, reliable, or resilient external counsel, you’ll find them here.

Find out who made the list for 2024: https://bit.ly/3W5kSt3

03/07/2024

World IP Review (WIPR), sister title to LSIPR, has launched its biggest and most comprehensive WIPR Leaders 2024 to date, profiling best-in-class IP practitioners across the length and breadth of the global IP community.

Read more on the launch here:

New-look WIPR Leaders 2024 is ‘most rigorous’ yet